$KRYS 3 SEC Filings

Filed On	Filing
06 Mar 2026	Form 3: Thomas John Charles, EVP, General Counsel Holds 642 shares of Common Stock
06 Mar 2026	Form 3: Goux Laurent Louis Jean, EVP, Head of International Holds 919 shares of Common Stock
09 Mar 2023	Form 3: Mazzacco Catherine, Director No securities owned
26 Jan 2022	Form 3: Sutherland Everett Rand, Director No securities owned
11 May 2021	Form 3: Orth Andrew C., Chief Commercial Officer Holds 100 shares of Common Stock
05 Jan 2021	Form 3: Marantz Jing L., Director No securities owned
05 Jan 2021	Form 3: Mason Christopher, Director No securities owned
25 Feb 2020	Form 3: Romano Kathryn, Chief Accounting Officer No securities owned
31 Jan 2020	Form 3: Chien Jennifer, Chief Commercial Officer No securities owned
06 Mar 2019	Form 3: Gangolli Julian S, Director No securities owned
24 May 2018	Form 3: Riley Antony A, Chief Financial Officer No securities owned
19 Sep 2017	Form 3: Sun Pharma (Netherlands) B.v., 10% owner Holds 914,107 shares of Series A Convertible Preferred Stock
19 Sep 2017	Form 3: Ganorkar Kirti, Director No securities owned
19 Sep 2017	Form 3: Rossi Dino A, Director Holds 123,691 shares of Series A Convertible Preferred Stock
19 Sep 2017	Form 3: Norby R Douglas, Director
19 Sep 2017	Form 3: Janney Daniel, Director Holds 130,590 shares of Common Stock
19 Sep 2017	Form 3: Krishnan Suma, Director Holds 1,835,249 shares of Common Stock
19 Sep 2017	Form 3: Krishnan Krish S, Director Holds 1,835,249 shares of Common Stock

Comments